| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |